Disposable Syringes Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Disposable 
Syringes Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  I MA R C  Gr o up ,  t i t l e d  " D i s p o sa b l e  S y r i n g e s  Ma r k e t :  
G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  Gr o w th ,  O p p o r t u n i t y  a n d  F o r e c as t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  d i s p o s ab l e  s y r i n g e s  ma r k e t  s i z e  r e a c h ed  U S $  1 5 . 1  B i l l i o n  i n  20 2 3 .
Fac tors  A f fec t ing  the  Growth  o f  t he  D isposab le  Syr inges  Indus t ry :
Report Increas ing  Pre fe rence  o f  Chronic  D iseases:
T he  r i s i n g  p r e va l e n c e  o f  ch r o n i c  d i se a s e s  w o r l d w i d e  i s  a  m a j o r  d r i v e r  o f  t h e  d i sp o s a b l e  
Highlight and sy r i n g e s  i n d u s t r y .  D i a b e t es ,  c a r d i o va s c u l a r  d i s e a s e ,  an d  au t o i mm u n e  i l l n e ss e s  a l l  ne c e s s i t a t e  r e g u l a r  i n j ec t i o n s  a nd  m o n i t o r i n g ,  w h i c h  i n c r e a se s  t h e  d em a n d  f o r  
d i sp o s a b l e  sy r i n g e s .  T h e  W o r l d  H e a l t h  O r g a n i za t i o n  ( W H O )  i n d i c a t e s  a  s i g n i f i c a n t  
Description g r o w t h  i n  c h r on i c  d i s e as e s ,  h i g h l i g h t i ng  t h i s  t r e n d .  
D i sp o s a b l e  sy r i n g e s  a r e  a  p o p u l a r  a l t e r n a t i v e  f o r  d i se a s e  ma n a g em e n t  be c a u se  t o  t h e i r  
co n v e n i en c e  o f  us e ,  sa f e t y ,  a n d  l o w  c o s t .  F u r t he r m o re ,  s i n g l e - u se  s y r i n g e s  r e d u ce  t h e  
po s s i b i l i t y  o f  c r os s - c on t a m i n a t i o n ,  a s s u r i n g  p a t i e n t  sa f e t y  a n d  a d h e r en c e  t o  m e d i ca l  
gu i de l i n e s .  A s  a  r e s u l t ,  t h e  r i s i n g  p r e v a l en c e  o f  c h ro n i c  i l l n e s se s  i s  d i r e c t l y  
p r o p o r t i on a l  t o  t h e  i n c r e a s i ng  d e ma n d  f o r  d i s po s a b l e  s y r i n ge s  i n  h ea l t h c a r e  s e t t i n g s .
Growing Emphasis  on In fect ion Contro l :
The  g rowing  emphas is  on  in fec t ion  con t ro l  and  sa f e t y  in  hea l thca re  se t t i ngs  i s  a  
ma jor  d r i ver  d r i v i ng  the  d isposab le  sy r inges  indus t ry .  The inc reased  know ledge o f  
t he  r i sks  connec ted  w i t h  r euse  sy r inges ,  such  as  the  sp read  o f  i n fec t ious  
d iseases  l i ke  H IV  and  hepat i t i s ,  has  resu l ted  in  s t r ingen t  leg i s la t ion  and po l i c ies  
Report encourag ing  t he  use  o f  d i sposab le  sy r inges .  
Hea l thcare  f ac i l i t i es  a re  i nc reas ing ly  us ing  s ing le -use  sy r inges  to  comp ly  w i t h  
Highlight and ru les  and main t a in  pa t ien t  sa f e t y .  The CO VI D-19 pandemic  has  emphas i zed  the  necess i t y  o f  i n fec t ion  management ,  f ue l ing  the  move toward  d isposab le  med ica l  
p roduc t s .  Th is  sh i f t  t oward  p r i o r i t i z ing  i n f ec t ion  con t ro l  and  reduc ing  c ross -
Description con tamina t i on  concerns  i s  a  c ruc ia l  f ac to r  d r i v i ng  t he  d i sposab le  sy r inges  
marke t ' s  sus ta ined  growth .
Technologica l  Advancements:
Ano the r  impor tan t  d r i ver  o f  t he  d isposab le  sy r inges  m arke t  i s  t echno log ica l  
improvemen t s  in  t he  m ed ica l  a rea .  I nnova t i ve  sy r inge  des igns ,  such  as  sa f e t y  
sy r i nges  and pre f i l l ed  sy r inges ,  have  improved  d rug  admin is t r a t i on  e f f i c i ency  and  
sa fe t y .  P re f i l l ed  sy r inges ,  in  par t i cu la r ,  a re  becoming popu la r  because  they  
e l im ina t e  d rug  e r ro rs  and  assu re  accu ra te  dos ing .
Fur thermore ,  the  deve lopment  o f  b io log ics  and  b ios im i la rs ,  wh ich  f requen t ly  
requ i re  in jec t ions ,  i s  d r iv ing  the  marke t  ahead .  These  deve lopments  no t  on ly  
inc rease  pa t ien t  sa fe ty ,  bu t  a l so  the  overa l l  exper ience  o f  hea l thca re  
p rov ide rs .  The  cons tan t  evo lu t ion  o f  med ica l  techno logy  is  expec ted  to  fue l  t he  
expans ion  o f  t he  d isposab le  sy r inges  marke t ,  in  l ine  w i th  the  demand fo r  more  
Report complex  and  user - f r i end ly  i n jec t ion  dev ices .
Highlight and Request  for  a  PDF sample  o f  th is  repor t :  h t tps : / /www. imarcgroup .com/d isposab le -sy r inges-marke t / requestsamp le
Description
Report Description
Global  Disposable Syr inges Market  Trends:
Env i ronmenta l  concerns re la ted to  the d isposa l  o f  medica l  was te ,  inc lud ing used  syr inges  a re  in f luenc ing  the  
marke t  dynamics .  Manufacture rs  a re  focus ing on deve lop ing  eco- f r iend ly  and  b iodegradab le  syr inges to  
address  these concerns and  comply  w i th  s t r ingen t  env i ronmenta l  regu la t ions .  The  emphas is  on  sus ta inab le  
prac t i ces  and the reduct ion  o f  medica l  was te  i s  expec ted  to  c reate  new oppor tun i t ies  fo r  innovat ion  and  
growth in  the d isposab le  sy r inges  marke t .  
Bes ides ,  the r i se  in  demand for  home hea l thcare  and se l f -admin is t ra t ion o f  medica t ions  i s  another  s ign i f ican t  
t rend in  the  d isposable  syr inges market .  Wi th  the  growing  ag ing  popula t ion and  the increas ing  p reva lence o f  
ch ron ic  d iseases,  pa t ien ts  are  opt ing  fo r  home-based t rea tments  tha t  o f fer  conven ience and comfor t .
Looking forward ,  the  market  to  reach US$ 27 .4  Bi l l ion  by  2032,  exhibi t ing  a  growth  ra te  (CAGR)  of  6 .7% 
dur ing  2024-2032.
View Report  TOC,  F igures and Tables :  h t tps: / /www. imarcgroup.com/d isposable-syr inges-market
Breakup by Product Type:
• Convent ional  Syringes
• Safety Syr inges
o Retractable Safety Syr inges
o Non-Retractable Safety Syr inges
Report 
Breakup by Application:
Segmentation • Immunizat ion Inject ions
• Therapeut ic In ject ions
Breakup by End User:
• Hospitals
• Diagnost ic Laboratories
• Others
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
Report • Middle East and Afr ica
Segmentation
• B. Braun Melsungen AG
• Baxter International  Inc.
• Becton Dickinson and Company
Competitive • Cardinal  Health Inc.
Landscape • Fresenius SE & Co. KGaA
• Henke-Sass Wolf GmbH
with Key • Nipro Corporat ion
Players • Novo Nordisk A/S
• Retractable Technologies Inc.
• Terumo Corporation
• Vita Needle Company
How has the global disposable syringes market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the global 
disposable syringes market?
Key 
What are the key regional markets?
Questions 
Answered in What is the breakup of the market based on the 
product type?
the Report
What is the breakup of the market based on the 
application?
What is the breakup of the market based on the end 
user?
What are the various stages in the value chain of the 
industry?
What are the key driving factors and challenges in the 
industry?
Key What is the structure of the global disposable syringes 
market and who are the key players?
Questions 
Answered in What is the degree of competition in the industry?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  D i s p o s a b l e  S y r i n g e s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     C o n v e n t i o n a l  S y r i n g e s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     S a f e t y  S y r i n g e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s
           6 . 2 . 2 . 1  R e t r a c t a b l e  S a f e t y  S y r i n g e s
           6 . 2 . 2 . 2  N o n - R e t r a c t a b l e  S a f e t y  S y r i n g e s
        6 . 2 . 3  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
       
    7 . 1     I m m u n i z a t i o n  I n j e c t i o n s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     T h e r a p e u t i c  I n j e c t i o n s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     H o s p i t a l s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     D i a g n o s t i c  L a b o r a t o r i e s
        8 . 2 . 1  M a r k e t  T r e n d s
Table of         8 . 2 . 2  M a r k e t  F o r e c a s t    8 . 3     O t h e r s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
Contents 9    M a r k e t  B r e a k u p  b y  R e g i o n    9 . 1     N o r t h  A m e r i c a
        9 . 1 . 1  U n i t e d  S t a t e s
           9 . 1 . 1 . 1  M a r k e t  T r e n d s
           9 . 1 . 1 . 2  M a r k e t  F o r e c a s t
        9 . 1 . 2  C a n a d a
           9 . 1 . 2 . 1  M a r k e t  T r e n d s
           9 . 1 . 2 . 2  M a r k e t  F o r e c a s t
    9 . 2     A s i a - P a c i f i c
        9 . 2 . 1  C h i n a
           9 . 2 . 1 . 1  M a r k e t  T r e n d s
           9 . 2 . 1 . 2  M a r k e t  F o r e c a s t
        9 . 2 . 2  J a p a n
           9 . 2 . 2 . 1  M a r k e t  T r e n d s
           9 . 2 . 2 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / d i s p o sa b le - s y r i n ge s - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: